FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/043932 [Registered on: 12/07/2022] Trial Registered Prospectively
Last Modified On: 12/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   Comparative analysis in dose requirement of propofol for induction of anaesthesia at varying time intervals after fentanyl administration - a Randomized clinical trial 
Scientific Title of Study   Comparative study of requirement of propofol for induction of anaesthesia with varying time intervals between fentanyl and propofol administration– a Randomized clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kannan G 
Designation  Post graduate Resident 
Affiliation  Chettinad Academy of Research and Education 
Address  Dept. of Anaesthesiology 1st floor, D Block, Chettinad Hospital and Research Institute OMR Kelambakkam

Chennai
TAMIL NADU
603103
India 
Phone  9677211422  
Fax    
Email  drkannansamuel@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Ashok Kulashekar 
Designation  Professor 
Affiliation  Chettinad Academy of Research and Education 
Address  Dept of Anaesthesiology 1st floor, D Block, Chettinad Hospital and Research Institute OMR Kelambakkam Chengalpattu

Chennai
TAMIL NADU
603103
India 
Phone  9840498420  
Fax    
Email  ashokk_dr@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Ashok Kulashekar 
Designation  Professor 
Affiliation  Chettinad Academy of Research and Education 
Address  Dept of Anaesthesiology 1st floor, D Block, Chettinad Hospital & Research Institute OMR, Kelambakkam

Chennai
TAMIL NADU
603103
India 
Phone  9840498420  
Fax    
Email  ashokk_dr@yahoo.com  
 
Source of Monetary or Material Support  
Chettinad Hsopital and Research Institute 
 
Primary Sponsor  
Name  Chettinad Hospital and Research Institute 
Address  OMR Kelambakkam Chennai-603103 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kannan  Chettinad Health and Research Institute  Dept of Anaethesiology, D Block 1st floor, Chetinad Hospital and Research Institute OMR Kelambakkam Chennai
Chennai
TAMIL NADU 
9677211422

drkannansamuel@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee for Student Research (CARE IHEC-I)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Propofol infusion, 5 min after Fentanyl administration   propofol infusion at 300 ml/hr 5 mins after Fentanyl administration while communicating verbally with the patient and will note the dose required to produce loss of verbal response. 
Intervention  Propofol infusion, 7 min after Fentanyl administration   propofol infusion at 300 ml/hr, 7 mins after Fentanyl administration while communicating verbally with the patient and will note the dose required to produce loss of verbal response. 
Comparator Agent  Propofol infusion, immediately after Fentanyl administration  propofol infusion at 300 ml/hr immediately after fentanyl administration while communicating verbally with the patient and will note the dose required to produce loss of verbal response 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Adult patients aged between 18 and 65 years
2) ASA-I & II physical status
3) Elective procedures under general anaesthesia
 
 
ExclusionCriteria 
Details  1) Patient not willing to be in the study group
2) Contraindication to GA
3) ASA-III & IV physical status
4) BMI > 35 kg/m2
5) Anticipated difficult airway
6) Pregnant patients
7) History of allergy to study drug
8) Drug abuse including chronic alcoholics
9) Emergency procedures
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To study the requirement of propofol for induction immediately, 5 and 7 mins after fentanyl administration
 
At baseline, 4 weeks and 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the incidence of movement, vocalization and additional propofol requirement  Soon after end of verbal response post induction 
 
Target Sample Size   Total Sample Size="108"
Sample Size from India="108" 
Final Enrollment numbers achieved (Total)= "108"
Final Enrollment numbers achieved (India)="108" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/07/2022 
Date of Study Completion (India) 30/09/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 

STUDY OBJECTIVE

Primary Objective

To study the requirement of propofol for induction immediately, 5 and 7 mins after fentanyl administration

 

Secondary Objective

To compare post induction hemodynamic changes, incidence of hypotension and fluid bolus requirement

To compare the incidence of movement, vocalization and additional propofol requirement

To compare incidence of apnea following induction

 

STUDY DESIGN - Randomized Clinical Trial

 

INCLUSION CRITERIA

Adult patients aged between 18 and 65 years

ASA-I & II physical status

Elective procedures under general anaesthesia

 

 

EXCLUSION CRITERIA

Patient not willing to be in the study group

Contraindication to GA

ASA-III & IV physical status

BMI > 35 kg/m2

Anticipated difficult airway

Pregnant patients

History of allergy to study drug

Drug abuse including chronic alcoholics

Emergency procedures

 

METHODOLOGY

1) All the patients will undergo routine pre-operative assessment in the pre-anaesthetic clinic.

2) Informed written consent will be obtained.

3) Patients will be randomized using a computer‑generated random numbers into one of the 3 groups

4) Patients will receive the premedication drugs Tab. Ranitidine 150mg and Tab. Alprazolam 0.5mg, night before surgery and in the morning of surgery.

5) On arrival to the operative room an IV access with 18 or 20 Gauge IV cannula will be secured.

6) In the operating room, standard preinduction monitors including electrocardiography, pulse oximetry, and noninvasive blood pressure will be attached and baseline heart rate and blood pressure will be recorded, followed by recordings at one‑minute intervals.

7) IV infusion with Ringer’s Lactate will be started at 10 ml/kg/hr and preoxygenated with 100% of Oxygen (O2) for 3 minutes

8) Fentanyl 2 mcgs/kg TBW will be administered.

9) Group 1 – Patients will be administered with Propofol, immediately after Fentanyl administration

10) Group 2 – Patients will be administered with Propofol, 5 min after Fentanyl administration

11) Group 3 – Patients will be administered with Propofol, 7 min after Fentanyl administration

12) Anaesthesiologist posted in the operating room will inject fentanyl and the time will be noted

13) An independent anaesthesiologist will be called in to start propofol injection using infusion pump according to group randomization.

14) The anaesthesiologist who administers propofol will start the pre-loaded propofol infusion at 300 ml/hr while communicating verbally with the patient and will note the dose required to produce loss of verbal response.

15) After checking for adequate ventilation, the patients will receive muscle relaxant – Inj. Atracurium 0.5mg/kg or Inj. Vecuronium 0.1mg/kg body weight IV.

16) In case of movement or vocalization, additional doses of  propofol in aliquots of 20 mg will be administered and the total dose administered will be noted

17) Incidence of apnea will be recorded

18) Pulse rate (PR), Systolic BP (SBP), Diastolic BP (DBP), Mean Arterial Pressure (MAP),and SpO2 will be noted every 2 minutes from fentanyl administration till induction of anaesthesia.

19) In case of hypotension following induction, IV bolus of 300 ml Ringer’s lactate will be given.

20) Hypotension not responding to fluid bolus will be treated using IV Phenylephrine

21) Occurrence of hypotension, bradycardia, requirement of fluid boluses, vasopressors and apnea following induction will be recorded.

 

END POINT - Loss of verbal response will be the endpoint of induction following propofol administration

 
Close